JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), a leading gifting company focused on inspiring customers to give more, connect more, and build more meaningful relationships, today reported results for its Fiscal 2027 first quarter ended September 27, 2026. “We entered fiscal 2027 with a clear priority on strengthening our primary websites, 1-800-Flowers.com and Harry & D...
JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) (the “Company”), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today announced that it has completed the previously announced sale of PersonalizationMall.com and Things Remembered to PlanetArt, LLC, a leading global technol...
JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS) (the “Company”), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today announced that it has entered into a definitive agreement to sell PersonalizationMall.com and Things Remembered to PlanetArt, LLC, a leading global techno...
1-800-Flowers.com (NASDAQ:FLWS) reported a bigger-than-expected loss for its fiscal fourth quarter and issued a downbeat profit forecast for fiscal 2027, sending shares down 9.3%. Revenue for the quarter came in at $293.1 million, missing estimates of $294 million and marking a 12.9% decline from a year earlier.
JERICHO, N.Y.--(BUSINESS WIRE)--1-800-FLOWERS.COM, Inc. (NASDAQ: FLWS), a leading provider of thoughtful expressions designed to help inspire customers to give more, connect more, and build more and better relationships, today reported results for its Fiscal 2026 fourth quarter and year ended June 28, 2026. “Fiscal 2026 was a year of meaningful progress as we strengthened the foundation of our ...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.